FHIR © HL7.org  |  FHIRsmith 4.0.1  |  Server Home  |  XIG Home  |  XIG Stats  | 

FHIR IG analytics

ValueSets, Realm US

14,182 resources

Source: Text:

By Version

By Authority

  • none: 1,981
  • hl7: 12,201

 

Start Prev Rows 6200 - 6400 Next

PackageVersionIdentityName/TitleStatusFMMWGDateAuthSource(s)
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.526.2.176.jsonArrhythmiaactive2017-05hl7icd
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.526.2.1766.jsonMorgagnian Cataractactive2021-02hl7icd
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.526.2.1767.jsonMorgagnian Cataractactive2021-02hl7sct
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.526.2.1769.jsonMacular Scar of Posterior Polaractive2021-02hl7icd
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.526.2.177.jsonAtrioventricular Blockactive2017-05hl7icd
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.526.2.1770.jsonMacular Scar of Posterior Polaractive2025-01hl7sct
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.526.2.1771.jsonOphthalmological Servicesactive2021-02hl7sct
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.526.2.1772.jsonAnnual Wellness Visitactive2024-02hl7sct
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.526.2.1773.jsonSpeech and Hearing Evaluationactive2019-03hl7sct
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.526.2.1774.jsonOccupational Therapy Evaluationactive2021-09hl7sct
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.526.2.1775.jsonBehavioral Neuropsych Assessmentactive2019-03hl7sct
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.526.2.1776.jsonPsych Visit Diagnostic Evaluationactive2020-03hl7sct
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.526.2.1777.jsonPsych Visit Psychotherapyactive2019-03hl7sct
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.526.2.1778.jsonPsychoanalysisactive2019-03hl7sct
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.526.2.1779.jsonGroup Psychotherapyactive2021-02hl7sct
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.526.2.178.jsonCardiac Pacer in Situactive2017-05hl7icd
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.526.2.1780.jsonPsych Visit for Family Psychotherapyactive2021-02hl7sct
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.526.2.1781.jsonBest Corrected Visual Acuity Exam Using Snellen Chartactive2021-02hl7loinc
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.526.2.180.jsonHypotensionactive2023-03hl7icd
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.526.2.181.jsonArrhythmiaactive2017-05hl7icd
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.526.2.183.jsonCardiac Pacer in Situactive2021-02hl7icd
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.526.2.185.jsonHypotensionactive2025-01hl7sct
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.526.2.186.jsonArrhythmiaactive2025-01hl7sct
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.526.2.187.jsonAtrioventricular Blockactive2025-01hl7sct
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.526.2.1912.jsonMajor Depressive Disorder Activeactive2023-02hl7sct
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.526.2.1918.jsonMajor Depressive Disorder Activeactive2023-02hl7icd
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.526.2.1923.jsonPsych Visit Diagnostic Evaluationactive2017-05hl7cpt
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.526.2.1924.jsonCardiac Pacer in Situactive2023-02hl7sct
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.526.2.408.jsonBradycardiaactive2024-02hl7sct
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.526.2.410.jsonBradycardiaactive2017-05hl7icd
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.526.2.411.jsonBradycardiaactive2017-05hl7icd
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.526.2.422.jsonTobacco Useractive2024-02hl7sct
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.526.2.423.jsonTobacco Use Cessation Pharmacotherapyactive2025-01hl7rx
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.526.2.424.jsonTobacco Use Cessation Counselingactive2017-05hl7cpt
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.526.2.425.jsonTobacco Use Cessation Counselingactive2023-02hl7sct
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.526.2.450.jsonPain Warranting Further Investigation for Prostate Canceractive2023-02hl7icd
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.526.2.469.jsonBilateral Oophorectomyactive2017-09hl7sct
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.526.2.470.jsonBilateral Oophorectomyactive2024-01hl7cpt
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.526.2.483.jsonChemotherapyactive2024-02hl7sct
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.526.2.484.jsonChemotherapyactive2021-08hl7cpt
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.526.2.511.jsonTobacco Non Useractive2024-02hl7sct
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.526.2.532.jsonPregnancyactive2025-01hl7sct
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.526.2.56.jsonCoronary Artery Disease No MIactive2017-05hl7icd
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.526.2.57.jsonCoronary Artery Disease No MIactive2024-02hl7icd
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.526.2.58.jsonInitial Myocardial Infarctionactive2024-02hl7sct
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.526.2.589.jsonEnd Stage Renal Diseaseactive2017-05hl7icd
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.526.2.59.jsonAsthmaactive2017-05hl7icd
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.526.2.590.jsonEnd Stage Renal Diseaseactive2017-05hl7sct
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.526.2.60.jsonAsthmaactive2017-05hl7icd
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.526.2.61.jsonAsthmaactive2025-01hl7sct
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.526.2.73.jsonPrimary Open Angle Glaucomaactive2021-02hl7icd
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.526.2.74.jsonPrimary Open Angle Glaucomaactive2025-01hl7sct
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.526.2.76.jsonDiabetic Retinopathyactive2021-02hl7icd
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.526.2.80.jsonDiabetic Retinopathyactive2025-01hl7sct
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.526.2.859.jsonLeft Ventricular Systolic Dysfunctionactive2017-05hl7sct
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.526.2.860.jsonModerate or Severeactive2017-05hl7sct
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.526.2.861.jsonModerate or Severe LVSDactive2017-05hl7sct
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.526.2.91.jsonProstate Canceractive2017-05hl7icd
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.526.2.92.jsonProstate Canceractive2025-03hl7sct
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.526.3.1002.jsonChronic Kidney Disease, Stage 5active2020-03hl7vsac
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.526.3.1005.jsonDementia and Mental Degenerationsactive2020-03hl7vsac
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.526.3.1006.jsonStandardized Tools Score for Assessment of Cognitionactive2022-03hl7vsac
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.526.3.1007.jsonMedical Reasonactive2022-03hl7vsac
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.526.3.1008.jsonPatient Reasonactive2022-03hl7vsac
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.526.3.1010.jsonCanceractive2022-03hl7vsac
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.526.3.1011.jsonOccupational Therapy Evaluationactive2022-03hl7vsac
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.526.3.1012.jsonPatient Provider Interactionactive2022-03hl7vsac
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.526.3.1018.jsonPsych Visit for Family Psychotherapyactive2022-03hl7vsac
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.526.3.1023.jsonBehavioral or Neuropsych Assessmentactive2022-03hl7vsac
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.526.3.1026.jsonRadiation Treatment Managementactive2022-03hl7vsac
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.526.3.1027.jsonChemotherapy Administrationactive2024-01hl7vsac
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.526.3.1028.jsonStandardized Pain Assessment Toolactive2022-03hl7vsac
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.526.3.1090.jsonModerate or Severe LVSDactive2022-03hl7vsac
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.526.3.1091.jsonLeft Ventricular Systolic Dysfunctionactive2022-03hl7vsac
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.526.3.1092.jsonModerate or Severeactive2022-03hl7vsac
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.526.3.1134.jsonEjection Fractionactive2022-03hl7vsac
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.526.3.1139.jsonACE Inhibitor or ARB or ARNIactive2021-02hl7vsac
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.526.3.1140.jsonPatient Reason for ACE Inhibitor or ARB Declineactive2022-03hl7vsac
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.526.3.1141.jsonPsychoanalysisactive2022-03hl7vsac
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.526.3.1151.jsonRenal Failure Due to ACE Inhibitoractive2022-03hl7vsac
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.526.3.1170.jsonTobacco Useractive2022-03hl7vsac
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.526.3.1174.jsonBeta Blocker Therapyactive2021-03hl7vsac
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.526.3.1176.jsonHeart Rateactive2022-03hl7vsac
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.526.3.1177.jsonAllergy to Beta Blocker Therapyactive2022-03hl7vsac
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.526.3.1178.jsonIntolerance to Beta Blocker Therapyactive2022-03hl7vsac
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.526.3.1184.jsonBeta Blocker Therapy for LVSDactive2017-05hl7vsac
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.526.3.1187.jsonGroup Psychotherapyactive2022-03hl7vsac
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.526.3.1189.jsonTobacco Non Useractive2022-03hl7vsac
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.526.3.1190.jsonTobacco Use Cessation Pharmacotherapyactive2017-05hl7vsac
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.526.3.1193.jsonCardiac Paceractive2022-03hl7vsac
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.526.3.1211.jsonAllergy to ACE Inhibitor or ARBactive2022-03hl7vsac
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.526.3.1212.jsonIntolerance to ACE Inhibitor or ARBactive2022-03hl7vsac
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.526.3.1240.jsonAnnual Wellness Visitactive2022-03hl7vsac
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.526.3.1241.jsonAcute and Subacute Iridocyclitisactive2021-02hl7vsac
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.526.3.1251.jsonMacular Examactive2022-03hl7vsac
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.526.3.1259.jsonLimited Life Expectancyactive2025-04hl7vsac
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.526.3.1278.jsonTobacco Use Screeningactive2022-03hl7vsac
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.526.3.1283.jsonLevel of Severity of Retinopathy Findingsactive2022-03hl7vsac
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.526.3.1285.jsonOphthalmological Servicesactive2022-03hl7vsac
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.526.3.1320.jsonMacular Edema Findings Presentactive2022-03hl7vsac
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.526.3.1332.jsonCognitive Assessmentactive2022-03hl7vsac
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.526.3.1333.jsonCup to Disc Ratioactive2022-03hl7vsac
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.526.3.1334.jsonOptic Disc Exam for Structural Abnormalitiesactive2022-03hl7vsac
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.526.3.1409.jsonBurn Confined to Eye and Adnexaactive2021-02hl7vsac
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.526.3.1410.jsonCataract Secondary to Ocular Disordersactive2021-02hl7vsac
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.526.3.1411.jsonCataract Surgeryactive2022-03hl7vsac
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.526.3.1412.jsonCataract Congenitalactive2021-02hl7vsac
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.526.3.1413.jsonCataract Mature or Hypermatureactive2021-02hl7vsac
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.526.3.1414.jsonCataract Posterior Polaractive2021-02hl7vsac
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.526.3.1415.jsonCertain Types of Iridocyclitisactive2021-02hl7vsac
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.526.3.1416.jsonChronic Iridocyclitisactive2021-02hl7vsac
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.526.3.1417.jsonCloudy Corneaactive2021-02hl7vsac
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.526.3.1418.jsonCorneal Edemaactive2021-02hl7vsac
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.526.3.1419.jsonDisorders of Cornea Including Corneal Opacityactive2021-02hl7vsac
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.526.3.1423.jsonGlaucomaactive2022-03hl7vsac
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.526.3.1424.jsonHereditary Corneal Dystrophiesactive2022-03hl7vsac
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.526.3.1426.jsonHypotony of Eyeactive2021-02hl7vsac
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.526.3.1427.jsonInjury to Optic Nerve and Pathwaysactive2022-03hl7vsac
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.526.3.1428.jsonCentral Corneal Ulceractive2021-02hl7vsac
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.526.3.1430.jsonOpen Wound of Eyeballactive2021-04hl7vsac
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.526.3.1432.jsonPathologic Myopiaactive2022-03hl7vsac
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.526.3.1433.jsonPosterior Lenticonusactive2021-03hl7vsac
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.526.3.1438.jsonRetrolental Fibroplasiasactive2021-02hl7vsac
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.526.3.1443.jsonTraumatic Cataractactive2021-02hl7vsac
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.526.3.1444.jsonUveitisactive2022-03hl7vsac
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.526.3.1445.jsonVascular Disorders of Iris and Ciliary Bodyactive2021-02hl7vsac
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.526.3.1446.jsonVisual Field Defectsactive2022-03hl7vsac
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.526.3.1448.jsonAmblyopiaactive2021-02hl7vsac
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.526.3.1450.jsonChoroidal Degenerationsactive2021-02hl7vsac
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.526.3.1451.jsonChoroidal Detachmentactive2021-02hl7vsac
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.526.3.1452.jsonChoroidal Hemorrhage and Ruptureactive2021-02hl7vsac
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.526.3.1453.jsonDegeneration of Macula and Posterior Poleactive2022-03hl7vsac
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.526.3.1454.jsonDegenerative Disorders of Globeactive2021-02hl7vsac
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.526.3.1455.jsonDiabetic Macular Edemaactive2021-02hl7vsac
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.526.3.1457.jsonDisorders of Optic Chiasmactive2021-02hl7vsac
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.526.3.1458.jsonDisorders of Visual Cortexactive2021-02hl7vsac
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.526.3.1459.jsonDisseminated Chorioretinitis and Disseminated Retinochoroiditisactive2021-02hl7vsac
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.526.3.1460.jsonFocal Chorioretinitis and Focal Retinochoroiditisactive2022-03hl7vsac
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.526.3.1461.jsonGlaucoma Associated with Congenital Anomalies and Dystrophies and Systemic Syndromesactive2022-03hl7vsac
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.526.3.1462.jsonHereditary Choroidal Dystrophiesactive2021-02hl7vsac
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.526.3.1463.jsonHereditary Retinal Dystrophiesactive2021-02hl7vsac
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.526.3.1465.jsonNystagmus and Other Irregular Eye Movementsactive2021-03hl7vsac
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.526.3.1466.jsonOptic Atrophyactive2021-02hl7vsac
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.526.3.1467.jsonOptic Neuritisactive2022-03hl7vsac
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.526.3.1468.jsonOther and Unspecified Forms of Chorioretinitis and Retinochoroiditisactive2022-03hl7vsac
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.526.3.1469.jsonOther Background Retinopathy and Retinal Vascular Changesactive2021-02hl7vsac
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.526.3.1471.jsonOther Disorders of Optic Nerveactive2021-02hl7vsac
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.526.3.1473.jsonOther Endophthalmitisactive2021-02hl7vsac
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.526.3.1475.jsonPrior Penetrating Keratoplastyactive2021-02hl7vsac
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.526.3.1477.jsonPurulent Endophthalmitisactive2021-02hl7vsac
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.526.3.1478.jsonRetinal Detachment with Retinal Defectactive2022-03hl7vsac
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.526.3.1479.jsonRetinal Vascular Occlusionactive2021-02hl7vsac
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.526.3.1480.jsonOther Proliferative Retinopathyactive2021-02hl7vsac
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.526.3.1482.jsonSeparation of Retinal Layersactive2021-02hl7vsac
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.526.3.1483.jsonVisual Acuity 20/40 or Betteractive2022-03hl7vsac
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.526.3.1491.jsonMajor Depressive Disorder Activeactive2021-02hl7vsac
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.526.3.1492.jsonPsych Visit Diagnostic Evaluationactive2022-03hl7vsac
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.526.3.1496.jsonPsych Visit Psychotherapyactive2022-03hl7vsac
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.526.3.1530.jsonSpeech and Hearing Evaluationactive2022-03hl7vsac
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.526.3.1558.jsonMorgagnian Cataractactive2021-02hl7vsac
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.526.3.1559.jsonMacular Scar of Posterior Polaractive2021-02hl7vsac
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.526.3.1560.jsonBest Corrected Visual Acuity Exam Using Snellen Chartactive2022-03hl7vsac
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.526.3.1561.jsonMedications for Above Normal BMIactive2021-02hl7vsac
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.526.3.1562.jsonMedications for Below Normal BMIactive2021-02hl7vsac
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.526.3.1563.jsonUnderweightactive2022-03hl7vsac
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.526.3.1566.jsonAdult Depression Medicationsactive2021-02hl7vsac
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.526.3.1567.jsonAdolescent Depression Medicationsactive2021-02hl7vsac
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.526.3.1568.jsonFollow Up for Adult Depressionactive2022-03hl7vsac
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.526.3.1569.jsonFollow Up for Adolescent Depressionactive2022-03hl7vsac
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.526.3.1570.jsonReferral for Adolescent Depressionactive2022-03hl7vsac
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.526.3.1571.jsonReferral for Adult Depressionactive2022-03hl7vsac
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.526.3.1572.jsonHigh Intensity Statin Therapyactive2021-02hl7vsac
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.526.3.1573.jsonLDL Cholesterolactive2025-02hl7vsac
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.526.3.1574.jsonLow Intensity Statin Therapyactive2021-02hl7vsac
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.526.3.1575.jsonModerate Intensity Statin Therapyactive2021-02hl7vsac
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.526.3.1576.jsonOutpatient Encounters for Preventive Careactive2022-03hl7vsac
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.526.3.1578.jsonFollow Up Within 4 Weeksactive2022-03hl7vsac
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.526.3.1580.jsonReferral to Primary Care or Alternate Provideractive2022-03hl7vsac
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.526.3.1581.jsonLifestyle Recommendationactive2022-03hl7vsac
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.526.3.1582.jsonPatient Declinedactive2022-03hl7vsac
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.526.3.1583.jsonReferral or Counseling for Alcohol Consumptionactive2022-03hl7vsac
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.526.3.1584.jsonHospice Care Ambulatoryactive2022-03hl7vsac
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.526.3.3000.jsonMetforminactive2019-12hl7vsac
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.526.3.319.jsonProstate Canceractive2020-03hl7vsac
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.526.3.320.jsonBone Scanactive2024-01hl7vsac
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.526.3.326.jsonPrimary Open Angle Glaucomaactive2022-03hl7vsac
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.526.3.327.jsonDiabetic Retinopathyactive2021-02hl7vsac
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.526.3.353.jsonEnd Stage Renal Diseaseactive2020-03hl7vsac
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.526.3.362.jsonAsthmaactive2022-03hl7vsac
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.526.3.366.jsonArrhythmiaactive2022-03hl7vsac
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.526.3.367.jsonAtrioventricular Blockactive2021-02hl7vsac
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.526.3.368.jsonCardiac Pacer in Situactive2022-03hl7vsac
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.526.3.369.jsonCoronary Artery Disease No MIactive2022-03hl7vsac
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.526.3.370.jsonHypotensionactive2020-03hl7vsac
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.526.3.371.jsonCardiac Surgeryactive2022-03hl7vsac
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.526.3.376.jsonHeart Failureactive2021-02hl7vsac
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.526.3.378.jsonPregnancyactive2021-02hl7vsac
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.526.3.398.jsonProstate Cancer Treatmentactive2025-02hl7vsac
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.526.3.399.jsonSalvage Therapyactive2022-03hl7vsac
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.526.3.401.jsonProstate Specific Antigen Testactive2022-03hl7vsac